HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[beta-galactosidosis--GM1 gangliosidosis and Morquio B disease].

Abstract
beta-galactosidosis is a lysosomal storage disorder caused by a deficiency of acid beta-galactosidase, including to autosomal recessive diseases; GM1-gangliosidosis (neurovisceral form) and Morquio B disease (skeletal form). To date, 26 different mutations in the beta-galactosidase gene have been identified in patients with beta-galactosidosis from various ethnic groups. Transient expression of the mutant genes has confirmed that mutant enzymes responsible for infantile GM1-gangliosidosis have almost no detectable beta-galactosidase activity. But the other three forms (late infantile/juvenile, adult/chronic GM1-gangliosidosis and Morquio B disease) are characterized by specific mutant enzymes with significant residual enzyme activity. Heterogeneous patterns of post-translational processing and maturation in these mutant enzymes are closely related to the phenotypic variations in beta-galactosidosis.
AuthorsK Yoshida, N Yanagisawa
JournalNihon rinsho. Japanese journal of clinical medicine (Nihon Rinsho) Vol. 53 Issue 12 Pg. 2960-6 (Dec 1995) ISSN: 0047-1852 [Print] Japan
PMID8577043 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • beta-Galactosidase
Topics
  • Age of Onset
  • Animals
  • Gangliosidosis, GM1 (etiology)
  • Humans
  • Mucopolysaccharidosis IV (etiology)
  • Mutation
  • beta-Galactosidase (deficiency, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: